Development of Safe Drugs: The hERG Challenge-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Safe Drugs: The hERG Challenge

Published:2017-05-03 Issue:2 Volume:38 Page:525-555
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Kalyaanamoorthy Subha¹,Barakat Khaled H.¹²³

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences; University Of Alberta; Edmonton Alberta Canada

2. Li Ka Shing Institute of Virology; University of Alberta; Edmonton Alberta Canada

3. Li Ka Shing Applied Virology Institute; University of Alberta; Edmonton Alberta Canada

Funder

Natural Sciences and Engineering Research Council of Canada

Li Ka Shing Applied Virology Institute

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference163 articles.

1. Clinical development success rates for investigational drugs;Hay;Nat Biotechnol,2014

2. Getting pharmaceutical R&D back on target;Bunnage;Nat Chem Biol,2011

3. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat Rev Drug Discov,2004

4. An analysis of the attrition of drug candidates from four major pharmaceutical companies;Waring;Nat Rev Drug Discov,2015

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying critical genes of breast cancer and corresponding leading compounds of potential therapeutic targets;2024-09-08

2. Synthesis, molecular docking, drug‐likeness analysis, and ADMET prediction of nickel and zinc tetraphenyl‐porphyrin complexes as possible antioxidant agents;Journal of the Chinese Chemical Society;2024-08-06

3. Synthesis of 2-aminothiazole sulfonamides as potent biological agents: Synthesis, structural investigations and docking studies;Heliyon;2024-08

4. Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists;Journal of Medicinal Chemistry;2024-05-24

5. Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization;ACS Chemical Neuroscience;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3